CYP2C9 c.643A>G ;(p.I215V)

Variant ID: 10-96708865-A-G

NM_000771.3(CYP2C9):c.643A>G;(p.I215V)

This variant was identified in 4 publications

View GRCh38 version.




Publications:


Differing Membrane Interactions of Two Highly Similar Drug-Metabolizing Cytochrome P450 Isoforms: CYP 2C9 and CYP 2C19.

International Journal Of Molecular Sciences
Mustafa, Ghulam G; Nandekar, Prajwal P PP; Bruce, Neil J NJ; Wade, Rebecca C RC
Publication Date: 2019-09-04

Variant appearance in text: CYP2C9: I215V
PubMed Link: 31487853
Variant Present in the following documents:
  • Main text
  • ijms-20-04328.pdf
View BVdb publication page



Insights into molecular mechanisms of drug metabolism dysfunction of human CYP2C9*30.

Plos One
Louet, Maxime M; Labbé, Céline M CM; Fagnen, Charline C; Aono, Cassiano M CM; Homem-de-Mello, Paula P; Villoutreix, Bruno O BO; Miteva, Maria A MA
Publication Date: 2018

Variant appearance in text: CYP2C9: I215V
PubMed Link: 29746595
Variant Present in the following documents:
  • Main text
  • pone.0197249.pdf
View BVdb publication page



Incorporation of charged residues in the CYP2J2 F-G loop disrupts CYP2J2-lipid bilayer interactions.

Biochimica Et Biophysica Acta
McDougle, Daniel R DR; Baylon, Javier L JL; Meling, Daryl D DD; Kambalyal, Amogh A; Grinkova, Yelena V YV; Hammernik, Jared J; Tajkhorshid, Emad E; Das, Aditi A
Publication Date: 2015-10

Variant appearance in text: CYP2C9: I215V
PubMed Link: 26232558
Variant Present in the following documents:
  • Main text
View BVdb publication page



Distal effect of amino acid substitutions in CYP2C9 polymorphic variants causes differences in interatomic interactions against (S)-warfarin.

Plos One
Lertkiatmongkol, Panida P; Assawamakin, Anunchai A; White, George G; Chopra, Gaurav G; Rongnoparut, Pornpimol P; Samudrala, Ram R; Tongsima, Sissades S
Publication Date: 2013

Variant appearance in text: CYP2C9: I215V
PubMed Link: 24023924
Variant Present in the following documents:
  • Main text
  • pone.0074053.pdf
View BVdb publication page